<div class="container">

<table style="width: 100%;"><tr>
<td>crmsim</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>CRM Simulator</h2>

<h3>Description</h3>

<p><code>crmsim</code> is used to generate simulation replicates of phase I
trial using the (group) CRM under a specified dose-toxicity
configuration.
</p>


<h3>Usage</h3>

<pre><code class="language-R">crmsim(PI, prior, target, n, x0, nsim = 1, mcohort = 1, restrict = TRUE, 
    count = TRUE, method = "bayes", model = "empiric", intcpt = 3, 
    scale = sqrt(1.34), seed = 1009) 
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>PI</code></td>
<td>
<p>A vector of the true toxicity probabilites associated with
the doses.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>prior</code></td>
<td>
<p>A vector of initial guesses of toxicity probabilities
associated with the doses.  Must be of same length as <code>PI</code>.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>target</code></td>
<td>
<p>The target DLT rate.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>n</code></td>
<td>
<p>Sample size of the trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>x0</code></td>
<td>
<p>The initial design.  For one-stage TITE-CRM, it is a
single numeric value indicating the starting dose.  For two-stage
TITE-CRM, it is a non-decreasing sequence of dose levels of length
<code>n</code>.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>nsim</code></td>
<td>
<p>The number of simulations.  Default is set at 1.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>mcohort</code></td>
<td>
<p>The number of patients enrolled before the next
model-based update.  Default is set at 1, i.e., a fully sequential
update.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>restrict</code></td>
<td>
<p>If TRUE, restrictions apply during the
trials to avoid (1) skipping doses in escalation and (2) escalation
immediately after a toxic outcome (i.e., incoherent escalation).  If
FALSE, dose assignments are purely model-based.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>count</code></td>
<td>
<p>If TRUE, the number of the current simulation replicate
will be displayed.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>method</code></td>
<td>
<p>A character string to specify the method for parameter
estimation.  The default method “bayes” estimates the model
parameter by the posterior mean.  Maximum likelihood estimation is
specified by “mle”.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>model</code></td>
<td>
<p>A character string to specify the working model used in
the method.  The default model is “empiric”.  A one-parameter
logistic model is specified by “logistic”.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>intcpt</code></td>
<td>
<p>The intercept of the working logistic model.  The
default is 3.  If <code>model</code>=“empiric”, this argument will be
ignored.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>scale</code></td>
<td>
<p>Standard deviation of the normal prior of the model
parameter.  Default is sqrt(1.34).</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>seed</code></td>
<td>
<p>Seed of the random number generator.</p>
</td>
</tr>
</table>
<h3>Value</h3>

<p>An object of class “sim” is returned, consisting of the operating
characteristics of the design specified.  The time component of the
design is suppressed for the CRM simulator.  All “sim” objects
generated by <code>crmsim</code> contain at least the following components:
</p>
<table>
<tr style="vertical-align: top;">
<td><code>PI</code></td>
<td>
<p>True toxicity rates.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>prior</code></td>
<td>
<p>Initial guesses of toxicity rates.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>target</code></td>
<td>
<p>The target probability of toxicity at the MTD.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>n</code></td>
<td>
<p>Sample size.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>x0</code></td>
<td>
<p>The initial design.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>MTD</code></td>
<td>
<p>Distribution of the MTD estimates.  If <code>nsim</code>=1, this
is a single numeric value of the recommended MTD of in simulated
trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>level</code></td>
<td>
<p>Average number of patients treated at the test doses.  If
<code>nsim</code>=1, this is a vector of length <code>n</code> indicating the
doses assigned to the patients in the simulated trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>tox</code></td>
<td>
<p>Average number of toxicities seen at the test doses.  If
<code>nsim</code>=1, this is a vector of length <code>n</code> indicating the
toxicity outcomes of the patients in the simulated trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>beta.hat</code></td>
<td>
<p>The estimates of the model parameter throughout the
simulated trial(s).  The dose assignment of the jth patient in each
trial corresponds to the jth element in each row.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>final.est</code></td>
<td>
<p>The final estimates of the model parameter of the
simulated trials.</p>
</td>
</tr>
</table>
<h3>References</h3>

<p>O'Quigley, J. O., Pepe, M., and Fisher, L. (1990).  Continual
reassessment method: A practical design for phase I clinical trials in
cancer.  Biometrics 46:33-48.
</p>
<p>Cheung, Y. K. (2005). Coherence principles in dose-finding studies.
Biometrika 92:863-873.
</p>
<p>Cheung, Y. K. (2011).  Dose Finding by the Continual Reassessment Method.  New York: Chapman &amp; Hall/CRC Press.
</p>


<h3>See Also</h3>

<p><code>crm</code>, <code>titesim</code>.
</p>


<h3>Examples</h3>

<pre><code class="language-R">PI &lt;- c(0.10, 0.20, 0.40, 0.50, 0.60, 0.65)
prior &lt;- c(0.05, 0.10, 0.20, 0.35, 0.50, 0.70)
target &lt;- 0.2
x0 &lt;- c(rep(1,3), rep(2,3), rep(3,3), rep(4,3), rep(5,3), rep(6,9))

# Generate a single replicate of two-stage group CRM trial of group size 3
foo &lt;- crmsim(PI, prior, target, 24, x0, mcohort=3)
## Not run: plot(foo,ask=T)  # summarize trial graphically

# Generate 10 replicates of CRM trial with 24 subjects
foo10 &lt;- crmsim(PI, prior, target, 24, 3, nsim=10, mcohort=2)
foo10
</code></pre>


</div>